Adaptability in Adversity: A Comparative Analysis of Tech and Pharmaceutical Sectors Amidst the Global Challenges
DOI:
https://doi.org/10.61173/ah738t62Keywords:
Global pandemic, Collaboration, Tech and Pharmaceutical industries, COVID-19Abstract
The tumultuous events of recent years, notably the global pandemic, have rigorously tested the adaptability and resilience of various sectors, with the tech and pharmacies- tical industries are emerging prominently. This review juxtaposes the trajectories of these two sectors, highlighting their unparalleled agility amidst challenges. The tech sector, capitalizing on the accelerated digital shift, not only sustained but often flourished, indicating a profound metamorphosis of conventional work paradigms. Conversely, the pharmaceutical industry showcased rapid R&D capabilities, emphasizing the power of collaboration and setting novel benchmarks in vaccine research. The review further explores the post-pandemic implications, predicting a future characterized by digital ubiquity in multiple fields, the potential of mRNA solutions beyond COVID-19, and a heightened emphasis on sustainability and corporate social responsibility. In summa- tion, the insights and strategies birthed during this period are poised to significantly shape the trajectories of both sectors, emphasizing adaptability, collaboration, and a renewed commitment to global welfare.
References
ing notable resilience. The tech industry not only R. (2021). How big tech got so big: Hundreds of weathered the storm but, in many instances, flourished, acquisitions. Washington Post. Re- retrieved from https:// leveraging the accelerated shift toward digital platforms. www.washingtonpost.com/technology/interactive/ 2021/ Simul- taneously, the pharmaceutical sector exhibited amazon-apple-facebook-google-acquisitions/
an unparalleled prowess in research, development, and Ayati, N., Saiyarsarai, P., & Nikfar, S. (2020). Short and international collaboration. While both sectors faced long-term impacts of covid-19 on the pharmaceutical distinct chal- lenges, they converged on familiar themes: sector. DARU Journal of Pharmaceutical Sci- ences, 28. innovation, agility, and a relentless drive to address Retrieved from https://link.springer.com/article/10.1007/ rapidly changing global needs, epitomized by their swift s40199-020-00358-5 doi: 10.1007/s40199-020-00358-5
pandemic responses. Bank, T. W. (2022). Chapter 1. the economic impacts of The strategies and innovations incubated during this the COVID-19 crisis. Re-retrieved from https://www. period are poised to leave an indelible mark on the post- worldbank.org/en/publication/wdr2022/brief/chapter-1- pandemic world. introduction-the-economic-impacts-of-the-covid-19-crisis
In the tech sector, the swift embrace of digital platforms Bhatt, G. (2020). Vaccine finance and epidemic risk – and remote work solutions has revolutionized conventional imf f&d. Re-retrieved from https://www.imf.org/en/ work paradigms. The emergence of hybrid work mod- Publications/fandd/issues/2020/09/vaccine-finance- Dean&Francis epidemics-and-prevention-bloom www.togai.com/blog/saas-recurring-revenue-models/
Fa jber, K. (2022). Business as usual? centering human Stevens, D. (2023). Investing in tech stocks: Opportunities rights to advance global covid-19 vaccine equity through and pitfalls. Re-retrieved 2023-09-19, from https:// covax. DOAJ (DOAJ: Directory of Open Access investinghaven.com/investment-ideas/investing-tech- Journals), 24, 219-228. stocks-opportunities-pitfalls/
Gao, J. (2021). Analysis of diversification strategy of Stijn, C., & Laura, K. (2014). The regulatory responses to apple inc. Academic Journal of Business & Management, the global financial crisis: Some uncomfortable questions. 3. Retrieved from https://francis-press.com/papers/503 International Monetary Fund. 6?msclkid=96202fd7a47f11ecb8dcfcd70eb83b49 doi: Whitaker, H. J., Tsang, R. S., Byford, R., Andrews, N. J., 10.25236/AJBM.2021.030908 Sherlock, J., Pillai, P. S., . . .Bernal, J. L. (2022). Pfizer-
Haider, A., & Rasay, S. J. (2020). Cloud growth biontech and oxford astrazeneca covid-19 vaccine effecskyrockets in q3 as covid-19 con- continues to accelerate tiveness and immune response among individuals in demand. Retrieved from https://www.spglobal.com/ clinical risk groups. Journal of Infection, 84. Retrieved market intelligence/en/news-insights/latest-news- from https://www.sciencedirect.com/science/article/pii/ headlines/cloud-growth-skyrockets-in-q3-as-covid-19- S0163445321006642 doi: 10.1016/j.jinf.2021.12.044 continues-to-accelerate-demand-61060162
Hinchliffe, D., & Britain., G. (2005). The influence of the pharmaceutical industry : Fourth report of session 2004- 05. vol. 1, report, together with formal minutes. Stationery Office. Kashte, S., Gulbake, A., El-Amin III, S. F., & Gupta, A. (2021, 03). Covid-19 vaccines: rapid development, implications, challenges and future prospects. Human Cell, 34. doi: 10.1007/s13577-021-00512-4
Kobzar, T. (2022). How can health kit and google fit power your healthcare and fit-ness apps. Retrieved from https://diversido.io/how-apples-healthkit-and-google-fit- APIs-help-in-health-and-fitness-apps-development/
Kollewe, J. (2021). From pfizer to moderna: who’s making billions from covid-19 vaccines? The Guardian. Retrieved from https://www.theguardian.com/business/2021/mar/06/ from-Pfizer-to-moderna-whos-making-billions-fromcovid-vaccines Md Khairi, L. N. H., Fahrni, M. L., & Lazzarino,
A. I. (2022). The race for global equitable access to covid-19 vaccines. Vaccines, 10, 1306. doi: 10.3390/ vaccines10081306
Peek, N., Sujan, M., & Scott, P. (2020). Digital health and care in pandemic times: impact of covid-19. BMJ Health & Care Informatics, 27, e100166. Retrieved from https:// informatics.bmj.com/content/27/1/e100166 doi: 10.1136/ bmjhci-2020-100166
Sethu, K. (2023). Saas recurring revenue models: Maximizing profits. Retrieved 2023-09-19, from https://
Downloads
Published
Issue
Section
License
Copyright (c) 2023 by the authors.

This work is licensed under a Creative Commons Attribution 4.0 International License.
